315 related articles for article (PubMed ID: 16409151)
21. Nuclear envelope-related lipodystrophies.
Guénantin AC; Briand N; Bidault G; Afonso P; Béréziat V; Vatier C; Lascols O; Caron-Debarle M; Capeau J; Vigouroux C
Semin Cell Dev Biol; 2014 May; 29():148-57. PubMed ID: 24384368
[TBL] [Abstract][Full Text] [Related]
22. LMNA-linked lipodystrophies: from altered fat distribution to cellular alterations.
Bidault G; Vatier C; Capeau J; Vigouroux C; Béréziat V
Biochem Soc Trans; 2011 Dec; 39(6):1752-7. PubMed ID: 22103520
[TBL] [Abstract][Full Text] [Related]
23. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13.
Magré J; Delépine M; Khallouf E; Gedde-Dahl T; Van Maldergem L; Sobel E; Papp J; Meier M; Mégarbané A; Bachy A; Verloes A; d'Abronzo FH; Seemanova E; Assan R; Baudic N; Bourut C; Czernichow P; Huet F; Grigorescu F; de Kerdanet M; Lacombe D; Labrune P; Lanza M; Loret H; Matsuda F; Navarro J; Nivelon-Chevalier A; Polak M; Robert JJ; Tric P; Tubiana-Rufi N; Vigouroux C; Weissenbach J; Savasta S; Maassen JA; Trygstad O; Bogalho P; Freitas P; Medina JL; Bonnicci F; Joffe BI; Loyson G; Panz VR; Raal FJ; O'Rahilly S; Stephenson T; Kahn CR; Lathrop M; Capeau J;
Nat Genet; 2001 Aug; 28(4):365-70. PubMed ID: 11479539
[TBL] [Abstract][Full Text] [Related]
24. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
[TBL] [Abstract][Full Text] [Related]
25. Lipodystrophy for the Diabetologist-What to Look For.
Patni N; Garg A
Curr Diab Rep; 2022 Sep; 22(9):461-470. PubMed ID: 35821558
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.
Vigouroux C; Caron-Debarle M; Le Dour C; Magré J; Capeau J
Int J Biochem Cell Biol; 2011 Jun; 43(6):862-76. PubMed ID: 21392585
[TBL] [Abstract][Full Text] [Related]
27. Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.
Nolis T
J Hum Genet; 2014 Jan; 59(1):16-23. PubMed ID: 24152769
[TBL] [Abstract][Full Text] [Related]
28. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus.
Jin J; Cao L; Zhao Z; Shen S; Kiess W; Zhi D; Ye R; Cheng R; Chen L; Yang Y; Luo F
Eur J Endocrinol; 2007 Dec; 157(6):783-7. PubMed ID: 18057387
[TBL] [Abstract][Full Text] [Related]
29. Mouse models of lipodystrophy and their significance in understanding fat regulation.
Rochford JJ
Curr Top Dev Biol; 2014; 109():53-96. PubMed ID: 24947236
[TBL] [Abstract][Full Text] [Related]
30. Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.
Navarro CL; Cadiñanos J; De Sandre-Giovannoli A; Bernard R; Courrier S; Boccaccio I; Boyer A; Kleijer WJ; Wagner A; Giuliano F; Beemer FA; Freije JM; Cau P; Hennekam RC; López-Otín C; Badens C; Lévy N
Hum Mol Genet; 2005 Jun; 14(11):1503-13. PubMed ID: 15843403
[TBL] [Abstract][Full Text] [Related]
31. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.
Navarro CL; De Sandre-Giovannoli A; Bernard R; Boccaccio I; Boyer A; Geneviève D; Hadj-Rabia S; Gaudy-Marqueste C; Smitt HS; Vabres P; Faivre L; Verloes A; Van Essen T; Flori E; Hennekam R; Beemer FA; Laurent N; Le Merrer M; Cau P; Lévy N
Hum Mol Genet; 2004 Oct; 13(20):2493-503. PubMed ID: 15317753
[TBL] [Abstract][Full Text] [Related]
32. Pathology of congenital generalized lipodystrophy in Agpat2-/- mice.
Vogel P; Read R; Hansen G; Wingert J; Dacosta CM; Buhring LM; Shadoan M
Vet Pathol; 2011 May; 48(3):642-54. PubMed ID: 21051554
[TBL] [Abstract][Full Text] [Related]
33. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.
Agarwal AK; Arioglu E; De Almeida S; Akkoc N; Taylor SI; Bowcock AM; Barnes RI; Garg A
Nat Genet; 2002 May; 31(1):21-3. PubMed ID: 11967537
[TBL] [Abstract][Full Text] [Related]
34. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation.
Afonso P; Auclair M; Boccara F; Vantyghem MC; Katlama C; Capeau J; Vigouroux C; Caron-Debarle M
Atherosclerosis; 2016 Feb; 245():200-11. PubMed ID: 26724531
[TBL] [Abstract][Full Text] [Related]
35. Genetic and phenotypic heterogeneity in patients with mandibuloacral dysplasia-associated lipodystrophy.
Simha V; Agarwal AK; Oral EA; Fryns JP; Garg A
J Clin Endocrinol Metab; 2003 Jun; 88(6):2821-4. PubMed ID: 12788894
[TBL] [Abstract][Full Text] [Related]
36. [Lipodystrophies].
Fischer-Posovszky P; Debatin KM; Wabitsch M
Klin Padiatr; 2002; 214(3):99-103. PubMed ID: 12015640
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the seipin and AGPAT2 genes clustering in consanguineous families with Berardinelli-Seip congenital lipodystrophy from two separate geographical regions of Brazil.
Gomes KB; Fernandes AP; Ferreira AC; Pardini H; Garg A; Magré J; Pardini VC
J Clin Endocrinol Metab; 2004 Jan; 89(1):357-61. PubMed ID: 14715872
[TBL] [Abstract][Full Text] [Related]
38. Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation.
Mory PB; Crispim F; Kasamatsu T; Gabbay MA; Dib SA; Moisés RS
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1252-6. PubMed ID: 19169477
[TBL] [Abstract][Full Text] [Related]
39. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways.
Agarwal AK; Garg A
Trends Endocrinol Metab; 2003 Jul; 14(5):214-21. PubMed ID: 12826327
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
